EHI
TXG icon

Eagle Health Investments’s 10x Genomics TXG Stock Holding History

Eagle Health Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-135,059
Closed -$5.07M – 30
2024
Q1 		$5.07M Buy
+135,059
New +$5.93M 0.94% 23
2023
Q1 		– Sell
-49,200
Closed -$1.79M – 29
2022
Q4 		$1.79M Hold
49,200
– – 0.41% 21
2022
Q3 		$1.4M Sell
49,200
-212,000
-81% -$8.08M 0.32% 23
2022
Q2 		$11.8M Buy
+261,200
New +$13.6M 2.76% 18

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Eagle Health Investments's TXG Position: Q2 2024 in Review

Eagle Health Investments sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 135,059 shares — an estimated $5.07M sold.

Eagle Health Investments first reported a position in TXG in Q2 2022 and held it in 4 quarters. The position peaked at $11.8M in Q2 2022. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Eagle Health Investments reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Eagle Health Investments sold 135,059 10x Genomics shares in Q2 2024, an estimated $5.07M.
  • Eagle Health Investments first reported a position in 10x Genomics in Q2 2022 and held it in 4 quarters.
  • Eagle Health Investments's 10x Genomics position peaked at $11.8M in Q2 2022.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Eagle Health Investments's 13F filing for Q2 2024, filed 13 Aug 2024.